WOOJUNG BIO, Inc. (KOSDAQ: 215380)

WOOJUNG BIO Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,161	5,416	3,577	455.29	4,109	4,705
Short-Term Investments	437.8	330	1,423	6,470	11,864	10,597
Cash & Short-Term Investments	2,599	5,746	5,000	6,926	15,973	15,302
Cash Growth	43.66%	14.93%	-27.80%	-56.64%	4.38%	-12.12%
Accounts Receivable	2,662	6,933	2,448	5,768	4,760	3,134
Other Receivables	109.65	35.05	20.73	243.64	69.14	29.95
Receivables	2,775	6,968	2,469	6,012	4,829	3,164
Inventory	4,358	4,338	3,586	4,390	3,761	4,837
Prepaid Expenses	94.06	111.89	98.45	137.43	76.66	171.88
Other Current Assets	2,614	2,526	2,734	7,704	3,610	9,981
Total Current Assets	12,440	19,690	13,887	25,169	28,250	33,457
Property, Plant & Equipment	53,417	56,130	63,715	57,281	35,650	19,297
Long-Term Investments	1,898	1,866	2,676	2,635	4,061	3,695
Other Intangible Assets	927.63	966.72	1,016	995.56	1,093	280.64
Long-Term Accounts Receivable	-0	-0	0	0	0	0
Long-Term Deferred Tax Assets	-	-	-	-	-	216.86
Other Long-Term Assets	19,452	19,680	13,700	14,056	762.42	685.44
Total Assets	88,135	98,333	94,994	100,136	69,816	57,632
Accounts Payable	1,356	1,134	1,406	1,578	1,273	1,880
Accrued Expenses	487.1	495.56	691.9	475.11	410.04	298.99
Short-Term Debt	25,398	25,647	22,618	10,575	8,202	6,507
Current Portion of Leases	437.72	468.54	207.33	407.47	601.32	412.11
Current Income Taxes Payable	-	-	-	-	2.94	-
Other Current Liabilities	6,455	17,953	20,320	24,506	6,877	18,894
Total Current Liabilities	34,134	45,699	45,244	37,542	17,366	27,992
Long-Term Debt	22,866	25,004	17,674	27,739	16,000	1,000
Long-Term Leases	863.04	1,197	186.52	356.22	595.18	218.7
Other Long-Term Liabilities	344.34	501.47	293.63	587.67	342.75	123.34
Total Liabilities	61,329	76,361	65,275	68,208	36,569	30,971
Common Stock	7,940	6,479	6,479	6,436	6,046	5,307
Additional Paid-In Capital	47,044	43,201	43,201	42,741	38,056	26,299
Retained Earnings	-25,585	-25,114	-18,397	-16,300	-14,654	-3,458
Treasury Stock	-2,006	-2,006	-2,006	-2,006	-2,006	-2,006
Comprehensive Income & Other	-587.01	-587.01	441.61	588.99	588.99	518.99
Total Common Equity	26,806	21,972	29,718	31,460	28,031	26,661
Shareholders' Equity	26,806	21,972	29,718	31,928	33,247	26,661
Total Liabilities & Equity	88,135	98,333	94,994	100,136	69,816	57,632
Total Debt	49,565	52,316	40,685	39,078	25,398	8,138
Net Cash (Debt)	-46,966	-46,570	-35,685	-32,152	-9,426	7,164
Net Cash Growth	-	-	-	-	-	-18.52%
Net Cash Per Share	-2621.61	-2962.34	-2771.02	-2688.00	-814.45	717.48
Filing Date Shares Outstanding	15.72	12.8	12.8	12.71	11.93	10.45
Total Common Shares Outstanding	15.72	12.8	12.8	12.71	11.93	10.45
Working Capital	-21,694	-26,008	-31,357	-12,373	10,884	5,465
Book Value Per Share	1705.17	1716.77	2322.02	2474.52	2348.89	2550.17
Tangible Book Value	25,879	21,005	28,702	30,465	26,939	26,380
Tangible Book Value Per Share	1646.16	1641.24	2242.63	2396.21	2257.33	2523.33
Land	2,858	2,858	8,986	2,837	-	-
Buildings	41,941	41,941	41,941	39,502	-	-
Machinery	15,479	15,437	15,152	13,898	4,820	4,022
Construction In Progress	81	70.84	4,279	4,260	32,529	16,466

Source: S&P Capital IQ. Standard template. Financial Sources.